Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
LLGL1
Introduction
Lethal(2) giant larvae protein homolog 1 is a protein that in humans is encoded by the LLGL1 gene.[1][2][3]
This gene encodes a protein that is similar to a tumor suppressor in Drosophila. The protein is part of a cytoskeletal network and is associated with nonmuscle myosin II heavy chain and a kinase that specifically phosphorylates this protein at serine residues. The gene is located within the Smith-Magenis syndrome region on chromosome 17.[3]
References
References
- ↑ Strand D, Unger S, Corvi R, Hartenstein K, Schenkel H, Kalmes A, Merdes G, Neumann B, Krieg-Schneider F, Coy JF, et al. (Aug 1995). “A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain”. Oncogene. 11 (2): 291–301. PMID 7542763.
- ↑ Koyama K, Fukushima Y, Inazawa J, Tomotsune D, Takahashi N, Nakamura Y (Mar 1996). “The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2”. Cytogenet Cell Genet. 72 (1): 78–82. doi:10.1159/000134167. PMID 8565641.
- ↑ 3.0 3.1 “Entrez Gene: LLGL1 lethal giant larvae homolog 1 (Drosophila)”.
Further reading
Further reading
- Campbell HD, Fountain S, Young IG, et al. (1997). “Genomic structure, evolution, and expression of human FLII, a gelsolin and leucine-rich-repeat family member: overlap with LLGL”. Genomics. 42 (1): 46–54. doi:10.1006/geno.1997.4709. PMID 9177775.
- Ludford-Menting MJ, Thomas SJ, Crimeen B, et al. (2002). “A functional interaction between CD46 and DLG4: a role for DLG4 in epithelial polarization”. J. Biol. Chem. 277 (6): 4477–84. doi:10.1074/jbc.M108479200. PMID 11714708.
- Bi W, Yan J, Stankiewicz P, et al. (2002). “Genes in a Refined Smith-Magenis Syndrome Critical Deletion Interval on Chromosome 17p11.2 and the Syntenic Region of the Mouse”. Genome Res. 12 (5): 713–28. doi:10.1101/gr.73702. PMC 186594. PMID 11997338.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Yamanaka T, Horikoshi Y, Sugiyama Y, et al. (2004). “Mammalian Lgl forms a protein complex with PAR-6 and aPKC independently of PAR-3 to regulate epithelial cell polarity”. Curr. Biol. 13 (9): 734–43. doi:10.1016/S0960-9822(03)00244-6. PMID 12725730.
- Grifoni D, Garoia F, Schimanski CC, et al. (2004). “The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo”. Oncogene. 23 (53): 8688–94. doi:10.1038/sj.onc.1208023. PMID 15467749.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Schimanski CC, Schmitz G, Kashyap A, et al. (2005). “Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer”. Oncogene. 24 (19): 3100–9. doi:10.1038/sj.onc.1208520. PMID 15735678.
- Kuphal S, Wallner S, Schimanski CC, et al. (2006). “Expression of Hugl-1 is strongly reduced in malignant melanoma”. Oncogene. 25 (1): 103–10. doi:10.1038/sj.onc.1209008. PMID 16170365.
- Grifoni D, Garoia F, Bellosta P, et al. (2007). “aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia”. Oncogene. 26 (40): 5960–5. doi:10.1038/sj.onc.1210389. PMID 17369850.